Motley Fool Australia

ResMed Inc (ASX: RMD) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Fundamental Company Figures

Data provided by Morningstar.
Market Cap $9.45 billion
P/E Ratio 41.32
Dividend Yield 0.60%
Shares Outstanding 1.46 billion
Earnings per share 0.479
Dividend per share 0.20
Year To Date Return -4.44%
Earnings Yield 2.42%
Franking N/A

Resmed Inc. (ASX: RMD) Latest News

asx blue chip shares represented by pile of blue casino chips in front of bar graph

2 brilliant blue chip ASX 200 shares to buy

More »

3 five-star ASX shares to buy in April

More »

top 5, 5, five

5 of the best ASX shares to buy after the Easter break

More »

Arisrtocrat share price value and growth ASX shares

2 of the best blue chip ASX shares to buy in April

More »

ASX 200 shares

ASX 200 up 0.4%: Bank shares lower, Xero shares upgraded

More »

Young female investor holding cash ASX retail capital return

Where to invest your BHP (ASX:BHP) dividends

More »

thumbs up

2 fantastic blue chip ASX shares that could be strong buys

More »

increase in asx medical software share price represented by doctor making excited hands up gesture

Bring your portfolio to life with these fantastic ASX healthcare shares

More »

Dividend Payment History

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
17 Aug 2016 $0.0300 0.00% Final 22 Sep 2016

Yearly Dividend Payment Chart

Data provided by Morningstar.

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About ResMed Inc (ASX: RMD)

Resmed Inc. (ASX: RMD) is a global healthcare company operating in the respiratory medical device space, particularly in the treatment of sleep apnoea.

The company is headquartered in San Diego, California, and develops and manufactures medical devices and cloud-based software applications that diagnose, treat and manage a number of respiratory disorders. These include sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases.

Resmed operates in more than 140 countries worldwide and has manufacturing facilities in Australia, Singapore, France, and the United States.

Resmed first listed on the ASX on 25 Nov 1999 and is now recognised as a blue chip healthcare share on the ASX 200 index.

Share Price History

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
09 Apr 2021 $25.97 $-0.05 -0.19% 2,079,159 $25.88 $25.97 $25.75
08 Apr 2021 $26.02 $-0.06 -0.23% 1,681,974 $26.08 $26.09 $25.80
07 Apr 2021 $26.08 $0.52 2.03% 1,407,037 $25.69 $26.21 $25.63
06 Apr 2021 $25.56 $-0.16 -0.62% 607,492 $25.70 $25.70 $25.44
01 Apr 2021 $25.72 $0.47 1.86% 1,568,291 $25.40 $25.74 $25.35
31 Mar 2021 $25.25 $0.21 0.84% 1,426,555 $25.00 $25.33 $24.85
30 Mar 2021 $25.04 $-0.05 -0.20% 892,013 $25.08 $25.21 $25.04
29 Mar 2021 $25.09 $0.21 0.84% 584,348 $25.13 $25.20 $24.93
26 Mar 2021 $24.88 $-0.35 -1.39% 1,155,624 $24.87 $24.90 $24.56
25 Mar 2021 $25.23 $-0.55 -2.13% 1,818,558 $25.55 $25.60 $25.07
24 Mar 2021 $25.78 $0.83 3.33% 2,167,869 $25.09 $25.78 $25.06
23 Mar 2021 $24.95 $0.79 3.27% 1,413,980 $24.44 $25.13 $24.40
22 Mar 2021 $24.16 $-0.10 -0.41% 820,032 $24.05 $24.23 $23.98
19 Mar 2021 $24.26 $-0.39 -1.58% 982,553 $23.86 $24.38 $23.75
18 Mar 2021 $24.65 $-0.38 -1.52% 1,747,198 $24.85 $24.90 $24.55
17 Mar 2021 $25.03 $0.54 2.20% 896,076 $24.66 $25.09 $24.66
16 Mar 2021 $24.49 $0.39 1.62% 1,743,230 $24.26 $24.58 $24.18
15 Mar 2021 $24.10 $-0.17 -0.70% 920,010 $24.08 $24.18 $23.94
12 Mar 2021 $24.27 $-0.06 -0.25% 961,102 $23.97 $24.60 $23.94
11 Mar 2021 $24.33 $0.45 1.88% 886,664 $24.00 $24.41 $23.82
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Dr Peter Craig Farrell Non-Executive Director,Non-Executive Chairman Jul 2002
Mr Ronald R Taylor Non-Executive Director Jan 2005
Mr Richard Sulpizio Non-Executive Director Aug 2005
Mr Michael J Farrell Chief Executive Officer,Executive Director Mar 2013
Ms Carol Burt Non-Executive Director Aug 2014
Ms Karen Drexler Non-Executive Director Aug 2018
Mr Jan De Witte Non-Executive Director May 2019
Ms Harjit Gill Non-Executive Director Nov 2018
Mr David Pendarvis Company Secretary
Brett Sandercock Chief Financial Officer
David Pendarvis Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Not disclosed in Annual Report 0 0.00%